Fact sheet: The Biotech Growth Trust PLC

Fund information

Fund name
The Biotech Growth Trust PLC
Fund company manager
Frostrow Capital LLP
Fund type
ITR
Fund manager(s)
Orbimed Capital
since 23/06/1997
Richard D Klemm
since 19/05/2005
Geoffrey C. Hsu
since 19/05/2005
Fund objective
The Biotech Growth Trust PLC seeks capital appreciation through investment in the worldwide biotechnology industry. Performance is measured against its benchmark index, the NASDAQ Biotechnology Index (sterling adjusted).
Benchmark
NASDAQ Biotechnology
Investment style
Growth
Investment method
-

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

25.9 %

1 Year rank in sector

2/4

Sector

IT Biotechnology & Healthcare

Yield
-
Fund size

£ 488.6 m

FE Risk score

222

NAV

915.79

Discount/Premium

+-4.4541

Gearing

109

Top in sector

Holdings snapshot

  • North America
    91.3%
  • Continental Europe
    5.5%
  • UK
    1.6%
  • Others
    1%
  • Not Specified
    0.6%
  • North American Equities
    91.3%
  • European Equities
    5.5%
  • International Equities
    1.6%
  • UK Equities
    1.6%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund7.39 %22.33 %25.9 %62.79 %190.7 %
Sector4.09 %11.35 %19.43 %77.21 %174 %
Rank within sector1 / 51 / 52 / 43 / 43 / 4
Quartile th1 st1 st2 nd3 rd3 rd

Calendar performance

YTD-20172016201520142013
Fund24.11 %-4.73 %9.14 %44.87 %60.14 %
Sector18.62 %6.22 %12.73 %39.34 %43.24 %
Rank within sector2 / 54 / 43 / 42 / 41 / 4
Quartile th2 nd4 th3 rd2 nd1 st

Risk statistics

Alpha-7.83
Beta1.34
Sharpe0.35
Volatility28.08
Tracking error12.41
Information ratio-0.3
R-Squared0.86

Price movement

52 week high878
52 week low627.75
Current bid price875
Current offer price880
Current mid price875

Holdings by region

  • 91.3% North America
  • 5.5% Continental Europe
  • 1.6% UK
  • 1% Others
  • 0.6% Not Specified

Holdings by sector

-

Holdings by asset type

  • 91.3% North American Equities
  • 5.5% European Equities
  • 1.6% International Equities
  • 1.6% UK Equities

Individual holdings

  • 12.6% BIOGEN INC
  • 11.8% CELGENE CORP
  • 9.3% VERTEX PHARMACEUTICAL
  • 7.1% REGENERON PHARMACEUTICALS INC
  • 6.2% ALEXION PHARMACEUTICALS INC
  • 5.8% INCYTE CORP
  • 5.3% AMGEN INC
  • 4.2% GILEAD SCIENCES INC
  • 4% ILLUMINA INC
  • 3.1% DBV TECHNOLOGIES